All articles published by MDPI are made immediately available worldwide under an open access license. No special
permission is required to reuse all or part of the article published by MDPI, including figures and tables. For
articles published under an open access Creative Common CC BY license, any part of the article may be reused without
permission provided that the original article is clearly cited. For more information, please refer to
https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature
Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for
future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive
positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world.
Editors select a small number of articles recently published in the journal that they believe will be particularly
interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the
most exciting work published in the various research areas of the journal.
As Evaluation Committee Chair of 2018 Vaccines Travel Awards, I am pleased toannounce the winners of the 2018 Vaccines Travel Awards.
We had many impressive applicants for this award from all over the world andchoosing was very difficult. Thanks to the Evaluation Committee’s thoroughdeliberation and reviews, the 2018 Travel Awards have been granted to Dr. Lynda Coughlan, a postdoctoral research fellow from Mount Sinai at IcahnSchool of Medicine, USA; and Mr. João Conniot, a PhD student from Universidadede Lisboa, Portugal. Please join us in congratulating them for their achievements.
Dr. Lynda Coughlan will be awarded 800 Swiss Francs towards participationat the “2nd International Meeting on Respiratory Pathogens” that will be heldon 7-9 March 2018 in Singapore. She will give an oral presentation for herwork entitled “Improving the immunogenicity of vaccine antigens delivered bynon-replicating adenoviral vectored vaccines by exosome-display”.
Mr. João Conniot will also be awarded 800 Swiss Francs towards participationat the “Frontiers in Immunomodulation and Cancer Therapy” that will be heldon 9-11 July 2018, Madrid, Spain. He will present his work entitled “DendriticCell-targeted Nano-vaccines Synergize with Immune Checkpoint Modulatorsfor Melanoma Treatment”.
Once again, we would like to thank all the applicants for participating, andacknowledge the members of the Evaluation Committee for their thoroughassessment of applicants. We are proud to support young scientists, and hopethose who weren’t chosen this time will apply for the 2019 Travel Awards.
Prof. Nirbhay Kumar Tulane University, New Orleans, LA, USA
